However, the lead genetic variants associated with these six genes in CD4+ T cell subtypes at different activation points were also associated with expression in multiple other tissues, for some genes including colon tissues, suggesting the effect of gene expression on CRC risk might not be entirely specific to CD4+ T cells. Here, CD4 is linked to colorectal carcinoma.